Sort
15,842 grants matching “pancreatic cancer”
Regulation of metastasis by alpha V integrin and Src
$361,229David A Cheresh · University Of California, San Diego · R01 · FY2010 · CA
Dissection and manipulation of RB function
$361,223Nicholas J Dyson · Massachusetts General Hospital · R01 · FY2012 · CA
Cellular Basis Of Action Of Gastrointestinal Peptides/Growth factors
$361,111Robert Jensen · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK
Dissection and manipulation of RB function
$361,050Nicholas J Dyson · Massachusetts General Hospital · R01 · FY2016 · CA
Dissection and manipulation of RB function
$361,050Nicholas J Dyson · Massachusetts General Hospital · R01 · FY2015 · CA
Intratumoral Metabolic Crosstalk Promotes Therapeutic Resistance in Pancreatic Cancer
$361,018Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor · R37 · FY2025 · CA
Metabolic vulnerability due to dysregulated lipid metabolism in PDAC cachexia
$361,006Aaron Grossberg · Oregon Health & Science University · R37 · FY2024 · CA
Dissecting the Function of Cysteine Cathepsins in the Tumor Microenvironment
$361,000Johanna Joyce · Sloan-Kettering Inst Can Research · R01 · FY2007 · CA
Dissecting the Function of Cysteine Cathepsins in the Tumor Microenvironment
$361,000Johanna Joyce · Sloan-Kettering Inst Can Research · R01 · FY2008 · CA
Dissecting the Function of Cysteine Cathepsins in the Tumor Microenvironment
$361,000Johanna Joyce · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA
Dissecting the Function of Cysteine Cathepsins in the Tumor Microenvironment
$361,000Johanna Joyce · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
Community Outreach and Engagement
$360,986Folakemi T Odedina · Mayo Clinic Rochester · P30 · FY2025 · CA
Molecular Basis of BRCA2-mediated DNA Repair and Cancer Avoidance
$360,929Patrick Sung · Yale University · R01 · FY2010 · ES
DNA Repair Pathways Choice to Regulate Therapeutic Resistance in Cancer Cells
$360,922Zihua Gong · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · CA
DNA Repair Pathways Choice to Regulate Therapeutic Resistance in Cancer Cells
$360,922Zihua Gong · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · CA
A Predictive Modeling Framework to Dissect the Dynamic Immunometabolic Responses to Pathogenic infection and the Kinetic Reprogramming of Metabolism in Cancer Cell System
$360,899Rajib Saha · University Of Nebraska Lincoln · R35 · FY2025 · GM
Dietary Regulation of Pancreatic Digestive Enzymes
$360,876John A Williams · University Of Michigan At Ann Arbor · R01 · FY2010 · DK
Mechanism of APE1 in DNA damage response
$360,794Shan Yan · University Of North Carolina Charlotte · R01 · FY2020 · CA
Targeting pancreatic cancer's metabolic addiction to HuR
$360,601Jordan M Winter · Case Western Reserve University · R37 · FY2019 · CA
Deploying Histotripsy Based Tumor Ablation Strategies to Treat Pancreatic Cancer
$360,593Irving C Allen · Virginia Polytechnic Inst And St Univ · R01 · FY2024 · CA
Electrophil elastase in lung cancer and COPD
$360,484Steven D Shapiro · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · HL
Electrophil elastase in lung cancer and COPD
$360,484Steven D Shapiro · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · HL
Alcohol-induced epigenetic alterations in human stem cells
$360,472Yong Kim · University Of California Los Angeles · R01 · FY2011 · AA
Targeting HuR to improve a synthetic lethal therapy for pancreatic cancer
$360,416Jonathan Brody · Oregon Health & Science University · R01 · FY2021 · CA
EARLY HEPATIC DISSEMINATION OF PANCREATIC CANCER: EFFECTIVE TREATMENT BY SYSTEMIC CHEMOTHERAPY-ENHANCED ALPHA-PARTICLE RADIOTHERAPY
$360,413The Johns Hopkins University · · FY2024 · Defense Health Agency